82 related articles for article (PubMed ID: 24898654)
1. The probable auto-antigenic role of lipids (anti-ganglioside antibodies) in the pathogenesis of Alzheimer's disease.
Koutsouraki E; Hatzifilippou E; Michmizos D; Banaki T; Costa V; Baloyannis S
J Alzheimers Dis; 2014; 42 Suppl 3():S163-6. PubMed ID: 24898654
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against gangliosides in patients with dementia.
Hatzifilippou E; Koutsouraki E; Costa VG; Baloyannis SJ
Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):660-6. PubMed ID: 24838532
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease.
Miura Y; Miyaji K; Chai YL; Chen CL; Lai MK; Yuki N
J Alzheimers Dis; 2014; 42(4):1165-9. PubMed ID: 25024341
[TBL] [Abstract][Full Text] [Related]
4. Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.
Ariga T; Kubota M; Nakane M; Oguro K; Yu RK; Ando S
PLoS One; 2013; 8(5):e63326. PubMed ID: 23717411
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to ganglioside GM1 in patients with Alzheimer's disease.
Chapman J; Sela BA; Wertman E; Michaelson DM
Neurosci Lett; 1988 Mar; 86(2):235-40. PubMed ID: 3368123
[TBL] [Abstract][Full Text] [Related]
6. Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.
Blennow K; Davidsson P; Wallin A; Fredman P; Gottfries CG; Månsson JE; Svennerholm L
Aging (Milano); 1992 Dec; 4(4):301-6. PubMed ID: 1294245
[TBL] [Abstract][Full Text] [Related]
7. Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
Illa I; Rojas R; Gallardo E; Serrano C; Graus F
Rev Neurol (Paris); 2001 May; 157(5):517-22. PubMed ID: 11438771
[TBL] [Abstract][Full Text] [Related]
8. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
9. Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited.
Kollewe K; Wurster U; Sinzenich T; Körner S; Dengler R; Mohammadi B; Petri S
PLoS One; 2015; 10(4):e0125339. PubMed ID: 25875836
[TBL] [Abstract][Full Text] [Related]
10. Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations.
Labrador-Horrillo M; Martinez-Valle F; Gallardo E; Rojas-Garcia R; Ordi-Ros J; Vilardell M
Lupus; 2012 May; 21(6):611-5. PubMed ID: 22323340
[TBL] [Abstract][Full Text] [Related]
11. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
12. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
Irie S; Saito T; Kanazawa N; Ito H; Kowa H
Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
[TBL] [Abstract][Full Text] [Related]
13. Motor nerve damage is associated with anti-ganglioside antibodies in diabetes.
Matà S; Betti E; Masotti G; Pinto F; Lolli F
J Peripher Nerv Syst; 2004 Sep; 9(3):138-43. PubMed ID: 15363061
[TBL] [Abstract][Full Text] [Related]
14. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
Tagawa Y; Matsumoto Y; Yuki N
No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
[TBL] [Abstract][Full Text] [Related]
15. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
16. Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features.
Cats EA; Jacobs BC; Yuki N; Tio-Gillen AP; Piepers S; Franssen H; van Asseldonk JT; van den Berg LH; van der Pol WL
Neurology; 2010 Nov; 75(22):1961-7. PubMed ID: 20962291
[TBL] [Abstract][Full Text] [Related]
17. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
18. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
19. Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors.
van Sorge NM; van den Berg LH; Geleijns K; van Strijp JA; Jacobs BC; van Doorn PA; Wokke JH; van de Winkel JG; Leusen JH; van der Pol WL
Ann Neurol; 2003 May; 53(5):570-9. PubMed ID: 12730990
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]